Kidney Week

Abstract: TH-PO582

Polymorphism in the Human Matrix Gla Protein Gene Is Associated with the Progression of Osteoporosis in Hemodialysis Patients

Session Information

• Bone and Mineral Metabolism: Bone Disease
  November 07, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
  Abstract Time: 10:00 AM - 12:00 PM

Category: Bone and Mineral Metabolism

• 402 Bone and Mineral Metabolism: Clinical

Authors

• Hasuike, Yukiko, Internal Medicine, Division of Kidney and Dialysis, Nishinomiya, Japan

Yukiko Hasuike,

• Kimura, Tomoko, Internal Medicine, Division of Kidney and Dialysis, Nishinomiya, Japan

Tomoko Kimura,

• Mizusaki, Kosuke, Internal Medicine, Division of Kidney and Dialysis, Nishinomiya, Japan

Kosuke Mizusaki,

• Kida, Aritoshi, Internal Medicine, Division of Kidney and Dialysis, Nishinomiya, Japan

Aritoshi Kida,

• Nanami, Masayoshi, Internal Medicine, Division of Kidney and Dialysis, Nishinomiya, Japan

Masayoshi Nanami,

• Nagasawa, Yasuyuki, Internal Medicine, Division of Kidney and Dialysis, Nishinomiya, Japan

Yasuyuki Nagasawa,

• Kuragano, Takahiro, Internal Medicine, Division of Kidney and Dialysis, Nishinomiya, Japan

Takahiro Kuragano,

• Ishihara, Masaharu, Internal Medicine, Division of Kidney and Dialysis, Nishinomiya, Japan

Masaharu Ishihara,

Background

Matrix Gla protein (MGP) is an important protein related osteoporosis and vascular calcification. Single nucleotide polymorphisms (SNPs) coding regions of the MGP gene affect the transcriptional activity. We investigated the relationship between the SNPs and progression of osteoporosis and vascular calcification in patients undergoing hemodialysis (HD).

Methods

This is a prospective and single center study. Using blood samples, SNPs on the MGP gene promoter T-138C (rs1800802, direct sequencing) was investigated. Bone mineral density (femoral, DEXA, T score) and vascular calcification index (ACI, abdominal CT) were examined at start and 1-year after. Several factors related bone: fibroblast growth hormone, bone-type alkaline phosphatase (BAP), and tartrate-resistant acid phosphatase (TRACP5b), uremia: Ca, P, parathyroid hormone-intact, and 25(OH) vitamin D, and inflammation: high-sensitivity CRP, tumor necrosis factor-α, interleukin-6 were measured. The change of T score and ACI were investigated.

Results

The distribution of the T-138C genotype was TT (47.5%), CT (40.0%) and CC (12.5%,). T score of all participants (n=80) at 1-year after was lower than that at start. T score for the CT and CC genotype were significantly decreased. The changes of T scores for the CC, CT, and TT genotype were shown (Figure 1a). The multiple regression analyses revealed that the change of BAP, TRACP-5b, and ACI were the independent predictors of T score change (standardized regression coefficients were -0.443, -0.276, and 0.400, respectively, R²=0.659). ACI for each genotype were increased (Figure 1b), and there were no differences of ACI change among 3 genotypes.

Conclusion

The MGP-138C genotype may be associated with decrease in T scores in HD patients. The genotype of the MGP gene might be a genomic biomarker that is predictive of osteoporosis.